Fujieda, Japan

Yukihiko Hara

This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Biotechnology Applications. Top assignees: Mitsui Norin Co., Ltd., Chinese Academy of Medical Sciences, Epitome Pharmaceuticals Limited. Active years: 1986-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukihiko Hara. Retrieved from https://idiyas.com/inventor/yukihiko-hara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 87.5


 

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 349(Granted Patents)


Location History:

  • Shizuoka, JP (1986 - 1990)
  • Fujieda, JP (1992 - 2001)
  • Tokyo, JP (2010 - 2014)

Company Filing History:


Years Active: 1986-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biocides
Disinfectants
Tea Polyphenols
Antiviral Compositions
Skin Compositions
Antibacterial Action
Hyperplasia Treatment
Natural Antioxidants
Dental Plaque Prevention
Hypertension Treatment
Tea Catechins
Chewing Gum
24 patents (USPTO):Explore Patents

Title: Innovations by Yukihiko Hara in Biocides and Disinfectants

Introduction

Yukihiko Hara, an accomplished inventor from Fujieda, Japan, holds an impressive portfolio of 24 patents. His work primarily focuses on developing innovative biocides and disinfectants aimed at combating various pathogens, including the notorious SARS virus.

Latest Patents

Among his recent inventions, Hara has developed compositions and methods that incorporate catechins derived from green tea. These formulations have shown effectiveness in inactivating SARS by at least a factor of 2 log 10 units when applied to surfaces. Additionally, his patent investigations into enhancing the susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) to antibiotics demonstrate his commitment to addressing pressing healthcare challenges. These methods propose the use of galloylated and non-galloylated catechins to further sensitize MRSA, enhancing treatment efficacy.

Career Highlights

Throughout his distinguished career, Yukihiko Hara has partnered with notable organizations such as Mitsui Norin Co., Ltd. and the Cancer Institute at the Chinese Academy of Medical Sciences. His work in these institutions has significantly contributed to advancements in the field of medical research and product development.

Collaborations

Hara has collaborated with esteemed colleagues, including Shu Jun Cheng and De Chang Wang. Together, they have been instrumental in pushing the boundaries of innovation in their field, leading to groundbreaking discoveries and inventions.

Conclusion

Yukihiko Hara's contributions to biocides and disinfectants illustrate the profound impact of innovative thinking in the scientific community. With a strong foundation of patentable work, he continues to pave the way for advancements in healthcare solutions, making a significant difference in infection control and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…